tradingkey.logo

Bristol Myers Squibb Provides Update On Phase 3 ODYSSEY-HCM Trial

ReutersApr 14, 2025 9:46 PM

- Bristol-Myers Squibb Co BMY.N:

  • BRISTOL MYERS SQUIBB PROVIDES UPDATE ON PHASE 3 ODYSSEY-HCM TRIAL

  • BRISTOL-MYERS SQUIBB CO - BMS PHASE 3 ODYSSEY-HCM TRIAL DID NOT MEET PRIMARY ENDPOINTS

  • BRISTOL-MYERS SQUIBB CO - NO NEW SAFETY SIGNALS OBSERVED IN ODYSSEY-HCM TRIAL

  • BRISTOL-MYERS SQUIBB CO - ODYSSEY-HCM TRIAL ENROLLED 580 PATIENTS WORLDWIDE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI